IVRS is launching a segment model on human pancreatic cancer!
Introducing our pancreatic cancer segment model. At IVRS AB we are constantly working on ways to expand our service array with robust and clinically relevant methods. We are thus proud to introduce a series of segment models, starting with our platform to validate drug candidates targeting pancreatic cancer. Our approach to a successful validatory study combines orthotopic […]
